The FDA has listed its advisory members for the committee that will discuss peptides in late July.
Owais Durrani, DO, an emergency medicine physician in Houston, previously wrote for Healio that “some of the most transformative drugs in modern medicine are peptides,” including insulin and semaglutide. While “the science of peptides is real, serious and worth pursuing,” Durrani wrote, the current system is messy: “a multi-billion-dollar market, a gray zone of unregulated suppliers, a regulatory system under political pressure, and real people spending real money on compounds that, for most of